131 related articles for article (PubMed ID: 38508241)
1. Phenotypes and ontogeny of senescent hepatic stellate cells in metabolic dysfunction-associated steatohepatitis.
Yashaswini CN; Qin T; Bhattacharya D; Amor C; Lowe S; Lujambio A; Wang S; Friedman SL
J Hepatol; 2024 Mar; ():. PubMed ID: 38508241
[TBL] [Abstract][Full Text] [Related]
2. Single cell-resolved study of advanced murine MASH reveals a homeostatic pericyte signaling module.
Bendixen SM; Jakobsgaard PR; Hansen D; Hejn KH; Terkelsen MK; Bjerre FA; Thulesen AP; Eriksen NG; Hallenborg P; Geng Y; Dam TV; Larsen FT; Wernberg CW; Vijayathurai J; Scott EAH; Marcher AB; Detlefsen S; Grøntved L; Dimke H; Berdeaux R; de Aguiar Vallim TQ; Olinga P; Lauridsen MM; Krag A; Blagoev B; Ravnskjaer K
J Hepatol; 2024 Mar; 80(3):467-481. PubMed ID: 37972658
[TBL] [Abstract][Full Text] [Related]
3. Secretome of senescent hepatic stellate cells favors malignant transformation from nonalcoholic steatohepatitis-fibrotic progression to hepatocellular carcinoma.
Zhou Y; Zhang L; Ma Y; Xie L; Yang YY; Jin C; Chen H; Zhou Y; Song GQ; Ding J; Wu J
Theranostics; 2023; 13(13):4430-4448. PubMed ID: 37649614
[No Abstract] [Full Text] [Related]
4. Mannan-Binding Lectin via Interaction With Cell Surface Calreticulin Promotes Senescence of Activated Hepatic Stellate Cells to Limit Liver Fibrosis Progression.
Luo J; Li L; Chang B; Zhu Z; Deng F; Hu M; Yu Y; Lu X; Chen Z; Zuo D; Zhou J
Cell Mol Gastroenterol Hepatol; 2022; 14(1):75-99. PubMed ID: 35381393
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil extracellular traps activate hepatic stellate cells and monocytes via NLRP3 sensing in alcohol-induced acceleration of MASH fibrosis.
Babuta M; Morel C; de Carvalho Ribeiro M; Calenda C; Ortega-Ribera M; Thevkar Nagesh P; Copeland C; Zhuang Y; Wang Y; Cho Y; Joshi R; Brezani V; Hawryluk D; Datta AA; Mehta J; Nasser I; Szabo G
Gut; 2024 May; ():. PubMed ID: 38777573
[TBL] [Abstract][Full Text] [Related]
6. Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype.
Schnabl B; Purbeck CA; Choi YH; Hagedorn CH; Brenner D
Hepatology; 2003 Mar; 37(3):653-64. PubMed ID: 12601363
[TBL] [Abstract][Full Text] [Related]
7. A long-acting FGF21 attenuates metabolic dysfunction-associated steatohepatitis-related fibrosis by modulating NR4A1-mediated Ly6C phenotypic switch in macrophages.
Ji Y; Duan Y; Li Y; Lu Q; Liu D; Yang Y; Chang R; Tian J; Yao W; Yin J; Gao X
Br J Pharmacol; 2024 Apr; ():. PubMed ID: 38679486
[TBL] [Abstract][Full Text] [Related]
8. Role of Hepatocyte Senescence in the Activation of Hepatic Stellate Cells and Liver Fibrosis Progression.
Wijayasiri P; Astbury S; Kaye P; Oakley F; Alexander GJ; Kendall TJ; Aravinthan AD
Cells; 2022 Jul; 11(14):. PubMed ID: 35883664
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Activity of Resolvin D1 (RvD1) in Murine MASH.
Navarro-Corcuera A; Zhu Y; Ma F; Gupta N; Asplund H; Yuan F; Friedman S; Sansbury BE; Huang X; Cai B
bioRxiv; 2024 Apr; ():. PubMed ID: 38712196
[TBL] [Abstract][Full Text] [Related]
10. Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice.
Cuño-Gómiz C; de Gregorio E; Tutusaus A; Rider P; Andrés-Sánchez N; Colell A; Morales A; Marí M
Biol Sex Differ; 2023 Nov; 14(1):85. PubMed ID: 37964320
[TBL] [Abstract][Full Text] [Related]
11. Targeting YAP-mediated HSC death susceptibility and senescence for treatment of liver fibrosis.
Du K; Maeso-Díaz R; Oh SH; Wang E; Chen T; Pan C; Xiang K; Dutta RK; Wang XF; Chi JT; Diehl AM
Hepatology; 2023 Jun; 77(6):1998-2015. PubMed ID: 36815382
[TBL] [Abstract][Full Text] [Related]
12. Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis.
Foglia B; Sutti S; Cannito S; Rosso C; Maggiora M; Casalino A; Bocca C; Novo E; Protopapa F; Ramavath NN; Provera A; Gambella A; Bugianesi E; Tacke F; Albano E; Parola M
Front Immunol; 2024; 15():1342404. PubMed ID: 38469298
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-10 induces senescence of activated hepatic stellate cells via STAT3-p53 pathway to attenuate liver fibrosis.
Huang YH; Chen MH; Guo QL; Chen ZX; Chen QD; Wang XZ
Cell Signal; 2020 Feb; 66():109445. PubMed ID: 31730896
[TBL] [Abstract][Full Text] [Related]
14. Extracellular vesicles from senescent hepatic stellate cells promote cell viability of hepatoma cells through increasing EGF secretion from differentiated THP-1 cells.
Miyazoe Y; Miuma S; Miyaaki H; Kanda Y; Nakashiki S; Sasaki R; Haraguchi M; Shibata H; Honda T; Taura N; Nakao K
Biomed Rep; 2020 Apr; 12(4):163-170. PubMed ID: 32190304
[TBL] [Abstract][Full Text] [Related]
15. Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis.
Bhattacharya D; Basta B; Mato JM; Craig A; Fernández-Ramos D; Lopitz-Otsoa F; Tsvirkun D; Hayardeny L; Chandar V; Schwartz RE; Villanueva A; Friedman SL
JHEP Rep; 2021 Jun; 3(3):100237. PubMed ID: 34151243
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil extracellular traps promote MASH fibrosis by metabolic reprogramming of HSC.
Xia Y; Wang Y; Xiong Q; He J; Wang H; Islam M; Zhou X; Kim A; Zhang H; Huang H; Tsung A
Hepatology; 2024 Jan; ():. PubMed ID: 38266270
[TBL] [Abstract][Full Text] [Related]
17. A novel A2a adenosine receptor inhibitor effectively mitigates hepatic fibrosis in a metabolic dysfunction-associated steatohepatitis mouse model.
Park S; Hwang S; Sun J; Jeon KH; Sheen N; Shin S; Kim TH; Lee YS; Seo W; Ryu JS; Kwon Y
Int J Biol Sci; 2024; 20(5):1855-1870. PubMed ID: 38481815
[TBL] [Abstract][Full Text] [Related]
18. Secreted folate receptor γ drives fibrogenesis in metabolic dysfunction-associated steatohepatitis by amplifying TGFβ signaling in hepatic stellate cells.
Quinn C; Rico MC; Merali C; Barrero CA; Perez-Leal O; Mischley V; Karanicolas J; Friedman SL; Merali S
Sci Transl Med; 2023 Sep; 15(715):eade2966. PubMed ID: 37756380
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of endogenous hydrogen sulfide production reduces activation of hepatic stellate cells via the induction of cellular senescence.
Damba T; Zhang M; Serna Salas SA; Wu Z; van Goor H; Arenas AF; Muñoz-Ortega MH; Ventura-Juárez J; Buist-Homan M; Moshage H
Cell Cycle; 2024 Jun; ():1-16. PubMed ID: 38836592
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice.
Kong X; Feng D; Wang H; Hong F; Bertola A; Wang FS; Gao B
Hepatology; 2012 Sep; 56(3):1150-9. PubMed ID: 22473749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
